GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of ARS 153.88 trillion. The enterprise value is 180.54 trillion.

Market Cap	153.88T
Enterprise Value	180.54T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 20, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.60%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	87.63%
Float	3.86B

Valuation Ratios

The trailing PE ratio is 13.78 and the forward PE ratio is 10.96.

PE Ratio	13.78
Forward PE	10.96
PS Ratio	2.41
PB Ratio	4.94
P/TBV Ratio	n/a
P/FCF Ratio	12.32
P/OCF Ratio	10.18
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 14.46.

EV / Earnings	16.17
EV / Sales	2.89
EV / EBITDA	8.18
EV / EBIT	9.99
EV / FCF	14.46

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	1.11
Debt / EBITDA	1.54
Debt / FCF	2.78
Interest Coverage	14.36

Financial Efficiency

Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.

Return on Equity (ROE)	43.31%
Return on Assets (ROA)	9.79%
Return on Invested Capital (ROIC)	26.53%
Return on Capital Employed (ROCE)	23.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	954.69M
Profits Per Employee	167.05M
Employee Count	66,841
Asset Turnover	0.54
Inventory Turnover	1.54

Taxes

In the past 12 months, GSK plc has paid 2.17 trillion in taxes.

Income Tax	2.17T
Effective Tax Rate	15.02%

Stock Price Statistics

The stock price has increased by +82.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+82.54%
50-Day Moving Average	20,689.80
200-Day Moving Average	17,346.13
Relative Strength Index (RSI)	48.87
Average Volume (20 Days)	474

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of ARS 63.81 trillion and earned 11.17 trillion in profits. Earnings per share was 2,711.36.

Revenue	63.81T
Gross Profit	46.34T
Operating Income	18.45T
Pretax Income	14.46T
Net Income	11.17T
EBITDA	22.14T
EBIT	18.45T
Earnings Per Share (EPS)	2,711.36

Balance Sheet

The company has 6.68 trillion in cash and 34.75 trillion in debt, giving a net cash position of -28,063.00 billion.

Cash & Cash Equivalents	6.68T
Total Debt	34.75T
Net Cash	-28,063.00B
Net Cash Per Share	n/a
Equity (Book Value)	31.17T
Book Value Per Share	7,972.82
Working Capital	-7,581.27B

Cash Flow

In the last 12 months, operating cash flow was 15.12 trillion and capital expenditures -2,633.23 billion, giving a free cash flow of 12.49 trillion.

Operating Cash Flow	15.12T
Capital Expenditures	-2,633.23B
Depreciation & Amortization	3.61T
Net Borrowing	2.42T
Free Cash Flow	12.49T
FCF Per Share	n/a

Margins

Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.

Gross Margin	72.61%
Operating Margin	28.92%
Pretax Margin	22.66%
Profit Margin	17.50%
EBITDA Margin	34.70%
EBIT Margin	28.92%
FCF Margin	19.57%

Dividends & Yields

This stock pays an annual dividend of 535.46, which amounts to a dividend yield of 2.61%.

Dividend Per Share	535.46
Dividend Yield	2.61%
Dividend Growth (YoY)	59.29%
Years of Dividend Growth	4
Payout Ratio	19.75%
Buyback Yield	0.60%
Shareholder Yield	3.24%
Earnings Yield	7.26%
FCF Yield	8.12%

Dividend Details

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7